SCHEMBL21248552

SCHEMBL21248552

Nc1c(-c2ccccc2)c(-c2ccccc2)c(O)c(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.43
PDE4B Q07343 2/20 0.43
PDE4C Q08493 2/20 0.43
PDE4D Q08499 2/20 0.43
HDAC4 P56524 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
ALDH1A1 P00352 5/20 0.40
HSD17B10 Q99714 4/20 0.40
MAPT P10636 3/20 0.40
LMNA P02545 3/20 0.40
HPGD P15428 3/20 0.40
HTT P42858 2/20 0.40
BCL2L1 Q07817 2/20 0.40
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
HSP90AA1 P07900 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL675595 0.87 ALDH1A1 (0.50) ALDH1A1HSD17B10MAPTLMNAHPGD
SCHEMBL1754108 0.87 PDE4B (0.52) PDE4APDE4BPDE4CPDE4DHDAC4
SCHEMBL223699 0.86 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DHDAC4
SCHEMBL5030574 0.84 HSD17B10 (0.48) ALDH1A1HSD17B10MAPTLMNAHPGD
SCHEMBL14353864 0.84 PDE4B (0.50) PDE4APDE4BPDE4CPDE4DHDAC4
SCHEMBL2207002 0.82 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DHDAC4
SCHEMBL1899394 0.81 HSD17B10 (0.46) ALDH1A1HSD17B10MAPTLMNAHPGD
SCHEMBL454643 0.81 PDE4B (0.54) PDE4APDE4BPDE4CPDE4DHDAC4
SCHEMBL29001722 0.81 PDE4B (0.58) PDE4APDE4BPDE4CPDE4DHDAC4
SCHEMBL28535205 0.81 ALDH1A1 (0.50) ALDH1A1HSD17B10MAPTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3749674-A1 MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2020-12-16 EP claimed
US-20200369697-A1 MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2020-11-26 US claimed
WO-2019157376-A1 MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2019-08-15 WO claimed
US-11702436-B2 Tetraphenylphenoxy tungsten oxo alkylidene complexes and methods of making same and use thereof VERBIO VEREINIGTE BIOENERGIE AG (DE) 2023-07-18 US disclosed
US-11702436-B2 Tetraphenylphenoxy tungsten oxo alkylidene complexes and methods of making same and use thereof VERBIO VEREINIGTE BIOENERGIE AG (DE) 2023-07-18 US disclosed
US-11702436-B2 Tetraphenylphenoxy tungsten oxo alkylidene complexes and methods of making same and use thereof VERBIO VEREINIGTE BIOENERGIE AG (DE) 2023-07-18 US disclosed
EP-3768691-A1 TETRAPHENYLPHENOXY TUNGSTEN OXO ALKYLIDENE COMPLEXES, METHODS OF MAKING SAME AND USE THEREOF Verbio Vereinigte BioEnergie AG (DE) 2021-01-27 EP disclosed
US-20210017207-A1 TETRAPHENYLPHENOXY TUNGSTEN OXO ALKYLIDENE COMPLEXES AND METHODS OF MAKING SAME AND USE THEREOF VERBIO SE (DE) 2021-01-21 US disclosed
US-20210017207-A1 TETRAPHENYLPHENOXY TUNGSTEN OXO ALKYLIDENE COMPLEXES AND METHODS OF MAKING SAME AND USE THEREOF VERBIO SE (DE) 2021-01-21 US disclosed
US-20200369697-A1 MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2020-11-26 US disclosed
WO-2019180230-A1 TETRAPHENYLPHENOXY TUNGSTEN OXO ALKYLIDENE COMPLEXES, METHODS OF MAKING SAME AND USE THEREOF XIMO AG (CH) 2019-09-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200369697-A1 MOLYBDENUM OXO ALKYLIDENE COMPOUNDS, METHODS OF MAKING THE SAME AND USE THEREOF IN METATHESIS REACTIONS MSRB3, MMAB, CYB5R3 PDE4A 3748/4885PDE4B 3559/4885PDE4C 3496/4885
US-20210017207-A1 TETRAPHENYLPHENOXY TUNGSTEN OXO ALKYLIDENE COMPLEXES AND METHODS OF MAKING SAME AND USE THEREOF PPOX, PPIP5K2, AOC1 PDE4A 4615/4885PDE4B 4761/4885PDE4C 4581/4885
US-11702436-B2 Tetraphenylphenoxy tungsten oxo alkylidene complexes and methods of making same and use thereof PPOX, PPIP5K2, AOC1 PDE4A 4615/4885PDE4B 4761/4885PDE4C 4581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.